Skip to main navigation Skip to search Skip to main content

The clinical and imaging features of hypertrophic pachymeningitis: a clinical analysis on 22 patients

  • Hao Chen
  • , Wei Zhang
  • , Jia Jing
  • , Hafiz Khuram Raza
  • , Zuohui Zhang
  • , Jienan Zhu
  • , Yonghai Liu
  • , Guiyun Cui
  • , Fang Hua
  • , Liguo Dong

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To explore the clinical and imaging features of patients with hypertrophic cranial pachymeningitis (HCP). Methods: A retrospective study was performed on 22 patients with HCP diagnosed at the Affiliated Hospital of Xuzhou Medical University from February 2014 to September 2017. Results: A headache was present as an initial symptom in 18 patients. The headache was associated with the loss of vision (2 cases), facial pain (1 case), and unsteady walking (1 case). Other symptoms included cranial nerve dysfunction (15 cases), cerebellar ataxia (4 cases), and sinus thrombosis (3 cases). In the laboratory tests, 7 patients showed an increased number of white blood cells, higher levels of C-reaction protein (CRP), and erythrocyte sedimentation rate (ESR). An elevated level of immunoglobulin G4 (IgG4) and the presence of the anti-neutrophil cytoplasmic antibody (ANCA) were found in 3 and 2 patients respectively. There were 17 patients who had abnormalities in their cerebrospinal fluid (CSF) on lumbar puncture. On magnetic resonance imaging (MRI), a local or generalized thickening was observed in the cerebral falx, the tentorium of the cerebellum, the fronto-parietal lobe, the occipito-parietal lobe, and the dura of skull base. A dural biopsy obtained in one case showed a variety of inflammatory changes. An immunohistochemical analysis revealed the positivity of CD138, IgG, and IgG4 in some cells. All 22 patients had a good response to corticosteroids. Conclusion: HCP mainly leads to a headache and the paralysis of multiple cranial nerves. A biopsy and MRI are often required and serve as the basis for the diagnosis and effective therapy.

Original languageEnglish (US)
Pages (from-to)269-274
Number of pages6
JournalNeurological Sciences
Volume40
Issue number2
DOIs
StatePublished - Feb 1 2019
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Headache
  • Hypertrophic pachymeningitis
  • MRI

ASJC Scopus subject areas

  • Dermatology
  • Clinical Neurology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'The clinical and imaging features of hypertrophic pachymeningitis: a clinical analysis on 22 patients'. Together they form a unique fingerprint.

Cite this